Individual Seed Projects

Utilizing the Immune Profile of Blood as a Biomarker for Transient Ischemic Attacks

Assistant Professor of Anesthesiology, Perioperative and Pain Medicine (Adult-MSD) at the Stanford University Medical Center
Neuroscience PhD Program Representative, Committee on Graduate Admissions and Policy (2017 - Present)

  • 300,000 people in the United States experience a TIA annually with over 10% suffering an ischemic stroke in the subsequent 90 days.
  • No effective biomarker currently exists.
  • Our approach identifies the immune profile of TIAs utilizing¬† state of the art immune monitoring - Mass Cytometry by Time Of Flight Mass Spectrometry (CyTOF)
  • Identification of these blood biomarkers will drastically change the current management of TIAs to prevent future strokes